Wanbangde Pharmaceutical Holding Group (002082.SZ) subsidiary's product, Huperzine A Injection, has been selected for inter-provincial alliance procurement.

date
16:20 11/08/2026
avatar
GMT Eight
ST Wanbang (002082.SZ) announced that its wholly-owned subsidiary, Wanbangde Pharmaceutical Group Co., Ltd., participated in the bidding for the inter-provincial alliance centralized bulk procurement of 34 types of medicines led by Henan Province. According to the "Inter-Provincial Alliance Procurement Office for 34 Types of Medicines" notice published on August 10, 2026, the company's product, Huperzine A Injection, was selected for this procurement.
Wanbangde Pharmaceutical Holding Group (002082.SZ) announced that its wholly-owned subsidiary, Wanbangde Pharmaceutical Group Co., Ltd., participated in the bidding for inter-provincial alliance centralized procurement of 34 types of medicines led by Henan Province. According to the "Inter-Provincial Alliance Procurement Office for 34 Types of Medicines," the procurement announcement (VIII) released on August 10, 2026, the company's product, Huperzine A Injection, was selected for this procurement. It is reported that Huperzine A Injection is suitable for benign memory disorders, enhancing patients' abilities in pointing memory, associative learning, image recall, recognition of meaningless figures, and human figure recall; it is also applicable for memory disorders caused by dementia and organic brain lesions. This selection is beneficial for securing the agreed procurement volume from public hospitals within the alliance, further expanding the sales scale of the selected product, and increasing Huperzine A Injection's national market share in the fields of cognitive disorders and treatment of myasthenia gravis.